BIOCHEMICAL SOCIETY TRANSACTIONS sequences probably mediate their effect by binding, in a sequence-specific manner, a protein which activates transcription. The recognition of elevated concentrations of heavy metals (for example, zinc) probably occurs by binding of the zinc ions to this hypothetical metal regulatory protein (MRP), such that normally only a low porportion of MRP has bound zinc. It is proposed that zinc (or other heavy metal ions) increases the affinity of M R P for the MREs. At normal concentrations of zinc most of MRP would not have zinc bound, and would therefore bind only weakly to MREs. Thus the MREs would be occupied by M R P only a small fraction of the time. Increased levels of zinc in the cell would lead to an increase in the concentration of the MRP-Zn complex. This would bind more tightly to the M REs, resulting in a higher occupancy. MRP bound in the promoter region of the gene is proposed to increase the rate of transcription initiation either by helping RNA polymerase I1 or some other essential transcription factor to bind, or by some other direct interaction with components of the transcriptional machinery leading to an increased rate of transcription initiation. Either apo-MRP or MRP-Zn might be equally effective at stimulating transcription when they are bound in the promoter region, in which case a low but significant occupancy of MREs by apo-MRP in the absence of elevated heavy metal concentrations could contribute to the basal level of expression of the gene. The multiple MREs present in MT gene promoters probably all contribute to the magnitude of the response; in at least some situations they can function co-operatively with each other as well as with other promoter elements that are not themselves responsive to heavy metals. Cytochromes P-450 are enzymes involved in the oxidative metabolism of steroids, fatty acids, prostaglandins, leukotrienes, biogenic amines, pheromones and plant metabolites (Boobis et al., 1985; Ortiz de Montellano, 1986). These mono-oxygenases also metabolize innumerable drugs, chemical carcinogens and mutagens, and other environmental contaminants. The molecular biology of the drugmetabolizing enzymes, especially the P-450s, has virtually exploded in the past several years. Accordingly, it is now possible to attempt to detect correlations between human P-450 gene expression and tumourigenesis or drug toxicity. This report summarizes several recent advances in this field.
Cytochromes P-450 are enzymes involved in the oxidative metabolism of steroids, fatty acids, prostaglandins, leukotrienes, biogenic amines, pheromones and plant metabolites (Boobis et al., 1985; Ortiz de Montellano, 1986) . These mono-oxygenases also metabolize innumerable drugs, chemical carcinogens and mutagens, and other environmental contaminants. The molecular biology of the drugmetabolizing enzymes, especially the P-450s, has virtually exploded in the past several years. Accordingly, it is now possible to attempt to detect correlations between human P-450 gene expression and tumourigenesis or drug toxicity. This report summarizes several recent advances in this field.
The P-450 gene superfamily
As a result of cDNA sequence data combined with chromosomal mapping data , the P-450 superfamily is presently known to comprise at least ten gene families (Fig. I ). Excluding the L1 family in yeast and the C1 family in Pseudomonas, the mammalian superfamily consists of at least eight P-450 gene Abbreviations used: AHH, aryl hydrocarbon hydroxylase; TCDD, 2.3,7,8-tetrachlorodibenzo-p-dioxin; RFLP, restriction fragment length polymorphism; EM, extensive metabolizer; PM, poor metabolizer.
families. There is sufficient homology between human and Pseudomonas P-450 in the region (21 amino acids) surrounding the haem-binding site near the C-terminus of the proteins (Adesnik & Atchison, 1986; Black & Coon, 1987) so as to make one conclude that both genes have diverged from a common ancestor . It is thus clear that the P-450 gene superfamily is ancient, having existed for more than 1.5 billion years, because the system is present in certain prokaryotes and in every eukaryote examined. Since P-450 proteins participate in the biosynthesis and degradation of steroids and catabolism of fatty acids, P-450 gene expression is probably essential for membrane integrity and turnover in these prokaryotes and all eukaryotes.
It is possible to divide the P-450 superfamily into families and subfamilies on the basis of percentage resemblance of amino acid sequences . Within the same species, a P-450 protein encoded by a gene in any one family is j 3 6 % similar to that encoded by a gene in any of the other families. P-450 proteins within the same subfamily are approx. 70% or more similar. Although six of the eight mammalian gene families studied so far have a single subfamily, the I1 and XI families have undergone more recent divergence into at least five and two subfamilies, respectively (Fig. I) . A P-450 protein encoded by a gene in any one subfamily is approx. 40-65% similar to that encoded by a gene in any of the other subfamilies within that family. T o date, the ten human and seven mouse P-450 subfamilies that have been given chromosomal assignments are consistent with the non-linked dispersion of each of these gene subfamilies more than 400 million years ago.
Human P-450 genes characterized to date
To date, 13 human P-450 cDNA clones have been com- Fig. 1 . Evolution of the P-450 gene superfamily The data were compiled from 67 P-450 full-length and nearly full-length cDNA and/or protein sequences available as of the end of January 1987 . The P450I gene family is regulated (inducible) by polycyclic aromatic compounds such as 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). The IIA subfamily in the rat is inducible by 3-methylcholanthrene (Nagata et a/., 1987) . The P450IIB subfamily and some IIC genes are inducible by phenobarbital. The IIE gene products are inducible by ethanol (Song C I al., 1986) . The P450III and P450IV families are induced by steroids and peroxisome proliferators (e.g. clofibrate), respectively. The P450IIA, IIC, IID, XIA and XIB subfamilies and the XVII, XIX and XXI gene families are expressed constitutively and/or are under hormonal regulation (e.g. adrenocorticotropic hormone, cyclic AMP). The XIA and XIB gene products are mitochondria1 proteins catalysing cholesterol side-chain cleavage and 1 ID-hydroxylation of steroids, respectively. The XVII, XIX and XXI gene products catalyse 17a-hydroxylation, androgen A-ring aromatization and 2 1 -hydroxylation of steroids, respectively. Whereas all the forementioned families exist in mammals, the LI and C1 gene families are present in yeast and Pseudomonadem. respectively. The Arabic numbers at the bottom of the Figure represent the minimal number of functional P-450 genes known to exist in human, yeast and bacteria, with the exception of one pseudogene of the two human 21 -hydroxylase genes described .
pletely sequenced . The remainder of this report will concentrate on important medical disorders that can be studied with this new knowledge.
Defects in cholesterol side-chain cleavage and I I fi-, 17a-and 2 I -hydroxylation of steroids are clinically important: absence of any of these four P-450 enzymes is associated with a variable degree of hyperandrogenism and cortisol deficiency (Speiser & New, 1985) . These defects are inherited as autosomal recessive traits, and the 21 -hydroxylase deficiency is by far the most common form of cogenital adrenal hyperplasia.
Laboratory animal studies have suggested that an increase in certain P-450 proteins is correlated with environmental carcinogenesis: P-45Oj (P4501IE1) with nitrosamine activation (Yang Ct at., 1985) , P,450 (P4501Al) with polycyclic hydrocarbon metabolism (Nebert, 1981) and P,450
Vol. 15 (P4501A2) with 2-acetylaminofluorene and aminobiphenyl activation (Thorgeirsson & Nebert, 1977; Kamataki et at., 1983) . It has been reported that the human debrisoquine 4-hydroxylase (P45011D1) defect may be associated with lung cancer (Ayesh et at., 1984) and with malignancy of the liver and gastrointestinal tract (Idle et at., 1981) . Since all of these human P-450 genes have been cloned , it should soon be possible to quantify the specific expression of one or more of these genes with cancer or toxicity caused by a variety of foreign substances and/or life styles.
The A h locus
This genetic system was named more than 15 years ago from the observation that a certain P-450-mediated activity [aryl hydrocarbon (benzpyrene) hydroxylase (AHH)] was highly inducible in some inbred mouse strains but not others ., 1983) . AHH catalyses the oxygenation of polycyclic hydrocarbons such as benzpyrene to phenolic products and epoxides, some of which are toxic, mutagenic and carcinogenic. The lack of AHH induction behaves as an autosomal recessive trait between C57BL/6 and DBA/2 mice, and the first inducing chemicals characterized were aromatic hydrocarbons (e.g. 3-methylcholanthrene and benzpyrene); hence, the name Ah locus. The Ah locus encodes the cytosolic Ah receptor, which is involved in the regulation of the P,450 and P,450 genes (P4501 family, Fig. 1 ).
Many molecular details of the Ah locus have been elucidated in the inbred mouse and via somatic cell genetics . After translocation of the TCDD-receptor complex to the nucleus, the expression of several genes is augmented. Included among the TCDD-inducible genes are P1450 and P,450, UDPglucuronosyltransferase, NAD(P)H : menadione oxidoreductase and glutathione transferase. The co-ordinate regulation of these five functionally related enzymes by the Ah receptor has been called the [Ah] gene battery . The P1450 and P,450 genes are known to be transcriptionally activated (Gonzalez et al., 1984) , and enhanced mRNA concentrations lead to increased levels of the PI 450 and P,450 proteins in the endoplasmic reticulum and corresponding rises in benzo[a]pyrene and acetanilide metabolism, respectively (Negishi et al., 1981 ).
There appears to be a highly significant correlation between high AHH inducibility and enhanced risk of bronchogenic carcinoma in cigarette smokers (Kouri et al., 1982; Gonzalez et al., 1987~) . This increased risk of polycyclic hydrocarbon-induced cancer for the high AHH inducibility phenotype has also been demonstrated in numerous studies with inbred mice (Kouri & Nebert, 1977; Nebert, 1981) . Ratio of AHH/NADH-cytochrome c reductase Fig. 2 . Comparison of P14.50 mRNA levels with AHH inducibility among six patients (Jaiswal et al., 19856 ) In order to quantify the PI mRNA concentrations, the integrated area under each densitometric peak for each PI mRNA slot blot was divided by the integrated area under each peak for the corresponding actin mRNA slot blot. Closed circles and bars denote the means f S.D. (n = 3) for both mRNA and enzyme determinations. Reproduced with permission from IRL Press.
The human PI 450 cDNA (Jaiswal et al., 1985a) and gene (Jaiswal et al., 19856) have been cloned and sequenced. By means of slot blots probed with the P1450 cDNA, human inducible PI 450 mRNA concentrations were found to be highly correlated with genetic differences in PI 450 enzymic activity (AHH) in mitogen-activated, 3-methylcholanthrenetreated lymphocyte cultures (Fig. 2) .
This assay of mRNA quantification requires more blood, however, than the AHH assay. The most ideal Ah phenotype test would be restriction fragment length polymorphism (RFLP) patterns, because such an assay could be easily carried out on the DNA from 5 ml of venepuncture blood.
Although two restriction enzymes have been found to produce human PI 450 restriction fragment polymorphisms, these RFLP patterns are not correlated with the Ah phenotype (Jaiswal et al., 198%; . The human P,450 cDNA and gene (K. Ikeya & A. K . Jaiswal, unpublished work) have also been sequenced, RFLP patterns have been found, yet no correlation with Ah phenotype has been observed. It is likely that this increased cancer risk due to high AHH inducibility reflects differences in one or more human regulatory genes, such as the Ah receptor gene, rather than the P,450 or P3450 structural genes.
The debrisoquine polymorphism
Eight to ten per cent of the Caucasian population of Europe and North America have an inherited deficiency of oxidative drug metabolism known as the debrisoquine polymorphism. Extensive metabolizers (EM) readily inactivate this antihypertensive drug, whereas homozygous autosomal recessive poor metabolizers (PM) are unable to do so (Idle & Smith, 1979 ; Price-Evans e f al., 1980; Kupfer & Preisig, 1983; Eichelbaum, 1984; Nakamura et al., 1985) . The defect extends to a growing list of more than 20 clinically used drugs including /I-adrenergic blocking agents such as bufuralol, anti-arrhythmia, antidepressants, hallucinogens, opioids and others. Individuals of the PM phenotype are at higher risk to develop adverse drug effects. A specific antibody has been developed against the rat debrisoquine 4-hydroxylase P-450dbl (Gonzalez et ul., 19876) , and this polyclonal antibody was found to cross-react very specifically with the human enzyme (P-450dbl) that hydroxylates debrisoquine and bufuralol (Gonzalez et al., 19874 . Levels of immunodetectable dbl protein were found to be highly correlated with bufuralol 1 '-hydroxylase activity in more than two dozen human liver samples; the protein was undetectable in several samples from PM individuals but readily detectable in all EM livers examined. The dbl gene was found to be linked to the SISproto-oncogene on human chromosome 22 .
In Northern blots of three PM individuals, five allelic products (mRNAs) were observed and subsequently named variants a (found twice), b, b' and c . In order to determine the nature of the mRNA defect from variant alleles a, b, b' and c, Lgtl I cDNA libraries were constructed and screened with the dbl cDNA probe. It was found that variant a (from two PM individuals) retained intron 5 (Fig. 3) , variant b (from the third PM individual) retained intron 6, and variant b' (from this same third PM individual) lost the 3' half of exon 6 in combination with the removal of intron 6; additionally, variant b' appeared to lack the first three exons, suggesting that transcription starts from a cryptic promoter in intron 3. Because every base of cDNA sequenced from variants b and b' was identical, it seems quite possible that the retention of intron 6 in variant b and the aberrant splice plus use of a cryptic promoter in variant b' arise from the same mutation(s), whatever it might be.
Variant c is less well understood. The normal-sized Fig. 3 . Diagram of the exons and approximate sizes of the eight introns of the human P-45Odbl gene, the normal splicing pattern of the wild-type ( w t ) pre-mRNA, and aberrant splicing patterns of the pre-mRNA from variants a , b and b (Gonzalez et al., 1 9 8 7~) The initiation of transcription of variant c mRNA most likely occurs from a cryptic promoter in intron 3 (see the text). The normal dbl protein (497 amino acids) is different from the prematurely terminated, truncated proteins of all three variants. The variant proteins appear to be unstable and probably so rapidly degraded that the anti-(rat)dbl cannot detect these defective gene products. variant c mRNA may have a mutation that gives rise to a normal-sized protein that is inefficiently inserted into the endoplasmic reticulum .
Using the human P450db1 cDNA insert as a probe, we have detected RFLPs in DNA isolated from normal volunteers. Restriction endonucleases that gave distinct RFLPs with the dbl cDNA include BamHI, BglII, EcoRI, HindIII, PstI and XbaI. Hence, very precise localization of the P450C2D gene on chromosome 22 is now feasible in family studies by RFLP linkage patterns using several of these previously mapped markers.
Conclusions
The field of P-450 gene cloning and sequencing has literally exploded in recent years. Of the 13 human P-450 genes cloned to date, most should prove useful in the diagnosis, treatment and understanding of numerous clinical disorders ranging from congenital adrenal hyperplasia and environmental carcinogenesis to idiosyncratic reactions in response to commonly prescribed drugs.
